CLINICAL_TRIALS
trial_result
· 2025-02-10
Clinical Trial Update: SOLACE Trial - A Phase 3 Trial in Subjects With Non-infectious Anterior-uveitis. [Phase 3]
Summary
The SOLACE Phase 3 trial evaluating reproxalap for non-infectious anterior uveitis has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Non-infectious Anterior Uveitis | Phase 3 | Status: COMPLETED | Results posted: 2025-02-10